Antimicrobial catheters are medical devices used in urinary systems and central venous catheters to prevent bacterial infections. They contain antimicrobial agents in their design or construction that prevent bacterial adhesion and biofilm formation. Antimicrobial catheters find widespread application in hospitals, specialty clinics, and long-term care facilities for procedures such as urinary catheterization, parenteral nutrition, chemotherapy, and hemodialysis. The growing geriatric population prone to urinary tract infections and increasing number of surgical procedures performed annually drive the demand for antimicrobial catheters.

The global antimicrobial catheter market is estimated to be valued at US$ 12591.03 Mn in 2023 and is expected to exhibit a CAGR of 11.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
One of the major drivers fueling the growth of the antimicrobial catheter market is the rising prevalence of hospital acquired or nosocomial infections. Nosocomial infections are infections acquired during the process of care in a hospital or healthcare service unit. According to the Centers for Disease Control and Prevention (CDC), around one in 25 hospital patients have at least one healthcare-associated infection on any given day. Nosocomial infections increase the cost of healthcare, length of hospital stay, antibiotic use, and mortality risk. The utilization of antimicrobial catheters helps curb the risk of catheter-associated urinary tract infections and bloodstream infections, thereby supporting market growth.

SWOT Analysis
Strength: Antimicrobial catheters help prevent catheter-associated urinary tract infections (CAUTIs) in patients. The coated antimicrobial agents effectively kill microbes entering through the catheter. This reduces patient pain and recovery time. It also lowers healthcare costs associated with longer hospital stays for CAUTI treatment.
Weakness: Antimicrobial catheters are more expensive than conventional catheters. There is also a risk of bacteria developing resistance to the coated antimicrobial agents after extended use.
Opportunity: Rising incidence of hospital-acquired infections worldwide increases the need for prevention. Antimicrobial catheters can help curb the growing threat of antimicrobial resistance if used judiciously.
Threats: Alternative non-pharmacological prevention methods may be adopted to avoid antimicrobial resistance issues. Economic slowdowns can dampen hospital expenditure on specialty catheters.

Key Takeaways

The global antimicrobial catheter market size is expected to witness high growth over the forecast period of 2023 to 2030.

Regional analysis: North America holds the largest share of the antimicrobial catheter market currently. The growing geriatric population vulnerable to UTIs and catheterizations drives regional market growth. However, Asia Pacific is emerging as the fastest growing regional market. Countries like China, Japan and India are witnessing increased access to modern healthcare technologies. Rising medical tourism is also boosting the APAC antimicrobial catheter market.

Key players: Key players operating in the antimicrobial catheter market are Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc. These top players focus on expanding portfolios through acquisitions and product launches to address clinician and hospital needs.

Get more insights on this topic: https://www.newsstatix.com/antimicrobial-catheter-market-propelled-by-rising-occurrence-of-hospital-acquired-infections/

Explore more information on this topic, Please visit: https://masstamilan.in/savoring-life-the-essential-role-and-health-benefits-of-spices-in-everyday-cuisine/